These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39180090)

  • 1. A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report.
    Berger M; Schumacher F; Wollsching-Strobel M; Kroppen D; Stanzel SB; Majorski DS; Fricke K; Plath I; Windisch W; Zimmermann M
    J Med Case Rep; 2024 Aug; 18(1):392. PubMed ID: 39180090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular and orbital manifestations in VEXAS syndrome.
    Abumanhal M; Leibovitch I; Zisapel M; Eviatar T; Edel Y; Ben Cnaan R
    Eye (Lond); 2024 Jun; 38(9):1748-1754. PubMed ID: 38548942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
    Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
    Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary manifestations in VEXAS syndrome.
    Casal Moura M; Baqir M; Tandon YK; Samec MJ; Hines AS; Reichard KK; Mangaonkar AA; Go RS; Warrington KJ; Patnaik MM; Koster MJ; Ryu JH
    Respir Med; 2023 Jul; 213():107245. PubMed ID: 37062498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome presenting as progressive multisystem involvement with parenchymal infiltrates following infection with Epstein Barr virus.
    Solujic J; Nguyen P; Bardy P; Ly Y; Lawton E
    Respirol Case Rep; 2024 Oct; 12(10):e70037. PubMed ID: 39398254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review.
    Kouranloo K; Ashley A; Zhao SS; Dey M
    Rheumatol Int; 2023 Jun; 43(6):1023-1032. PubMed ID: 36617363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEXAS syndrome: Current clinical, diagnostic and treatment approaches.
    Kobak S
    Intractable Rare Dis Res; 2023 Aug; 12(3):170-179. PubMed ID: 37662628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports.
    Echerbault R; Bourguiba R; Georgin-Lavialle S; Lavigne C; Ravaiau C; Lacombe V
    Rheumatology (Oxford); 2024 Oct; 63(10):2694-2700. PubMed ID: 38407378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic manifestations of VEXAS syndrome.
    Groarke EM; Dulau-Florea AE; Kanthi Y
    Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I diagnose and manage VEXAS syndrome.
    Hagiya A; Siddiqi IN; Wang E; Lu CM
    Am J Clin Pathol; 2024 Jul; 162(1):28-40. PubMed ID: 38511841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent orbital inflammation associated with VEXAS syndrome.
    Beecher MB; Tong JY; Halliday LA; Hissaria P; Selva D
    Orbit; 2024 Jun; 43(3):350-353. PubMed ID: 36168114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.
    Tan IJ; Ferrada MA; Ahmad S; Fike A; Quinn KA; Groarke EM; Beck DB; Allbritton J; Castelo-Soccio L; Young NS; Patel BA; Grayson PC; Cowen EW
    JAMA Dermatol; 2024 Aug; 160(8):822-829. PubMed ID: 38865133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis in VEXAS syndrome.
    Oo TM; Koay JTJ; Lee SF; Lee SMS; Lim XR; Fan BE
    J Thromb Thrombolysis; 2022 May; 53(4):965-970. PubMed ID: 34817788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
    Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
    JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease.
    Philip R; Cadro V; Aouba A; Chantepie S; Bracquemart C; Dumont A
    Joint Bone Spine; 2024 Jul; 91(4):105731. PubMed ID: 38583690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.